Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reported that among patients aged 19 to 60 who experienced hair loss after COVID-19, a treatment involving a complex drug and peptide lotion led to hair improvement in 92% of cases, with good tolerability and no reported side effects.

In this article, the authors concluded that despite diverse causes of diffuse hair loss, modern therapies can effectively manage the condition without side effects, as demonstrated in two clinical cases of telogen effluvium.

In this study, researchers observed that a new peptide complex helped increase hair density in postmenopausal patients with female-type hair loss by promoting the transition of hair follicles from a resting stage to a growth stage.

In this study, the use of Selencin, both in tablet and peptide lotion form, over two months showed significant improvements in reducing hair loss and restoring hair structure and volume in patients with diffuse alopecia, with effects persisting up to four months after treatment.

This study found that a serum with a minoxidil derivative and high-concentration niacinamide was effective in improving androgenetic alopecia in women, with 65.8% showing clinical recovery after 4 months, and reported good tolerability and increased treatment compliance.